Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001079249 | SCV001126679 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000978745 | SCV001153529 | likely benign | not provided | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002416250 | SCV002729134 | likely benign | Inborn genetic diseases | 2020-07-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001277133 | SCV001463961 | likely benign | Dyskeratosis congenita, autosomal dominant 1 | 2020-06-05 | no assertion criteria provided | clinical testing |